EUVIMEDEUVIMED entdecken
Open Access

Elongation factor 1A1 inhibition elicits changes in lipid droplet size, the bulk transcriptome, and cell type-associated gene expression in MASLD mouse liver

Rachel B Wilson iD, Yun Jin Chen, Richard Zhang, Siddhant Maini iD, Tallulah S Andrews, Rennian Wang iD, Nica M Borradaile iD

American Journal of Physiology-Gastrointestinal and Liver Physiology · 2024

DOI: 10.1152/ajpgi.00276.2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, 2024. Verfasst von Rachel B Wilson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. Hauptthemen laut MEDLINE: Peptide Elongation Factor 1, Lipid Droplets, Transcriptome, Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Canadian Government | Canadian Institutes of Health Research (CIHR), Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemical inhibition of EEF1A1 decreases hepatic lipid droplet size and decreases gene expression signatures associated with liver cell types that contribute to MASLD progression. Furthermore, changes in hepatic gene expression are primarily attributable to hepatocytes and cholangiocytes. This work highlights the therapeutic potential of targeting EEF1A1 in the setting of MASLD, and the utility of RNA-Seq deconvolution to reveal valuable information about tissue cell type composition and cell type-associated gene expression from bulk RNA-Seq data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peptide Elongation Factor 1Lipid DropletsTranscriptomeLiverAnimalsMiceMaleFatty LiverHepatocytesDisease Models, AnimalNon-alcoholic Fatty Liver Disease

Stichwörter der Autor:innen

EEF1A1MASLDlipid dropletliver biology

Substanzen

Peptide Elongation Factor 1

Autor:innen und Institutionen

  • Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
  • Children's Health Research Institute, Lawson Health Research Institute, London, Ontario, Canada.
  • Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.

ORCID-Profile: Rachel B Wilson, Siddhant Maini, Rennian Wang, Nica M Borradaile

Förderung

  • Canadian Government | Canadian Institutes of Health Research (CIHR)
  • Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC)

Zitieren

APA

Wilson, R. B., Chen, Y. J., Zhang, R., Maini, S., Andrews, T. S., Wang, R., & Borradaile, N. M. (2024). Elongation factor 1A1 inhibition elicits changes in lipid droplet size, the bulk transcriptome, and cell type-associated gene expression in MASLD mouse liver. American Journal of Physiology-Gastrointestinal and Liver Physiology. https://doi.org/10.1152/ajpgi.00276.2023

Vancouver

Wilson RB, Chen YJ, Zhang R, Maini S, Andrews TS, Wang R, et al. Elongation factor 1A1 inhibition elicits changes in lipid droplet size, the bulk transcriptome, and cell type-associated gene expression in MASLD mouse liver. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2024. doi:10.1152/ajpgi.00276.2023

BibTeX
@article{Wilson2024,
  author = {Wilson, Rachel B and Chen, Yun Jin and Zhang, Richard and Maini, Siddhant and Andrews, Tallulah S and Wang, Rennian and Borradaile, Nica M},
  title = {Elongation factor 1A1 inhibition elicits changes in lipid droplet size, the bulk transcriptome, and cell type-associated gene expression in MASLD mouse liver},
  journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
  year = {2024},
  doi = {10.1152/ajpgi.00276.2023}
}
Kostenlos starten →